Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Cubist Pharmaceuticals, Inc. v. Hospira, Inc., No. 15-1197 (Fed. Cir. Nov. 12, 2015)

Errata Correction sheet to a previously issued opinion
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 15-1197
Also Docketed
No. 15-1204, No. 15-1259 (consolidated; same document)
Decided
November 12, 2015
Judge
Document
Errata
Length
1 page

United States Court of Appeals

for the Federal Circuit

December 23, 2015

ERRATUM

Appeal Nos. 2015-1197, 2015-1204, 2015-1259 CUBIST PHARMACEUTICALS, INC.,

Plaintiff-Cross-Appellant

v.

HOSPIRA, INC.,

Defendant-Appellant Decided: November 12, 2015

Precedential Opinion

The following change has been made on page 24, line 29 of the opinion: change “legal” to “reversible.”

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Cubist Pharmaceuticals, Inc. v. Hospira, Inc., No. 15-1197 (Fed. Cir. Nov. 12, 2015).

govinfo ID
USCOURTS-ca13-15-01197-1
Permalink
https://patentcasewatch.com/opinions/USCOURTS-ca13-15-01197-1

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.